Friday, Dec. 4, 2015, 88 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $23.60 to $7,551,056.93.

Highlighted Stocks Traded by Insiders:

Ellington Residential Mortgage REIT (EARN) - FREE Research Report

Miller David, who is Director at Ellington Residential Mortgage REIT, bought 4,901 shares at $12.92 on Dec. 4, 2015. Following this transaction, the Director owned 16,281 shares meaning that the stake was boosted by 43.07% with the 4,901-share transaction.

The shares most recently traded at $12.81, down $0.11, or 0.87% since the insider transaction. Historical insider transactions for Ellington Residential Mortgage REIT go as follows:

  • 4-Week # shares bought: 5,099
  • 12-Week # shares bought: 5,099
  • 24-Week # shares bought: 5,099

The average volume for Ellington Residential Mortgage REIT has been 41,100 shares per day over the past 30 days. Ellington Residential Mortgage REIT has a market cap of $116.4 million and is part of the financial sector and real estate industry. Shares are down 21.76% year-to-date as of the close of trading on Friday.

Ellington Residential Mortgage REIT, a real estate investment trust, specializes in acquiring, investing in, and managing residential mortgage-and real estate-related assets. The stock currently has a dividend yield of 14.13%. Currently, there are no analysts who rate Ellington Residential Mortgage REIT a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EARN - FREE

TheStreet Quant Ratings rates Ellington Residential Mortgage REIT as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full Ellington Residential Mortgage REIT Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Suburban Propane Partners (SPH) - FREE Research Report

Zwickel Sandra N, who is Vice President,Human Resources at Suburban Propane Partners, sold 2,700 shares at $28.00 on Dec. 4, 2015. Following this transaction, the Vice President,Human Resources owned 20,735 shares meaning that the stake was reduced by 11.52% with the 2,700-share transaction.

The shares most recently traded at $24.76, down $3.24, or 13.09% since the insider transaction. Historical insider transactions for Suburban Propane Partners go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 1,500
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 1,500
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 2,118

The average volume for Suburban Propane Partners has been 236,900 shares per day over the past 30 days. Suburban Propane Partners has a market cap of $1.7 billion and is part of the utilities sector and utilities industry. Shares are down 38.63% year-to-date as of the close of trading on Friday.

Suburban Propane Partners, L.P., through its subsidiaries, engages in the retail marketing and distribution of propane, fuel oil, and refined fuels. The stock currently has a dividend yield of 13.04%. The company has a P/E ratio of 19.7. Currently, there are 3 analysts who rate Suburban Propane Partners a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SPH - FREE

TheStreet Quant Ratings rates Suburban Propane Partners as a hold. The company's strongest point has been its expanding profit margins. At the same time, however, we also find weaknesses including a generally disappointing performance in the stock itself and feeble growth in the company's earnings per share. Get the full Suburban Propane Partners Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Mallinckrodt (MNK) - FREE Research Report

Romano Steven J., who is Sr. VP & Chief Scientific Ofcr at Mallinckrodt, bought 700 shares at $72.60 on Dec. 4, 2015. Following this transaction, the Sr. VP & Chief Scientific Ofcr owned 4,026 shares meaning that the stake was boosted by 21.05% with the 700-share transaction.

The shares most recently traded at $71.93, down $0.67, or 0.93% since the insider transaction. Historical insider transactions for Mallinckrodt go as follows:

  • 4-Week # shares bought: 9,045
  • 4-Week # shares sold: 668
  • 12-Week # shares bought: 9,345
  • 12-Week # shares sold: 668
  • 24-Week # shares bought: 18,026
  • 24-Week # shares sold: 668

The average volume for Mallinckrodt has been 3.4 million shares per day over the past 30 days. Mallinckrodt has a market cap of $8.4 billion and is part of the health care sector and drugs industry. Shares are down 24.54% year-to-date as of the close of trading on Friday.

Mallinckrodt public limited company develops, manufactures, markets, and distributes specialty pharmaceutical and biopharmaceutical products, and nuclear imaging agents in the United States, Europe, the Middle East, Africa, and internationally. The company has a P/E ratio of 27.7. Currently, there are 10 analysts who rate Mallinckrodt a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MNK - FREE

TheStreet Quant Ratings rates Mallinckrodt as a sell. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk and generally disappointing historical performance in the stock itself. Get the full Mallinckrodt Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.